Evidence map›Paper›PMID 22905672›Full record

ArticleJournal of neurochemistry2012

Adolescent rats are resistant to adaptations in excitatory and inhibitory mechanisms that modulate mesolimbic dopamine during nicotine withdrawal.

Luis A Natividad, Matthew W Buczynski, Loren H Parsons, Oscar V Torres, Laura E O'Dell

Open access · greenAbstract read
In one paragraph

Article in Journal of neurochemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Unique, long-term effects of nicotine on adolescent brain.Pharmacology, biochemistry, and behavior · 2020
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Diacylglycerol lipase disinhibits VTA dopamine neurons during chronic nicotine exposure.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Luis A NatividadDepartment of Psychology, The University of Texas, El Paso, TX, USA.
Matthew W Buczynski
Loren H Parsons
Oscar V Torres
Laura E O'Dell
The University of Texas at El Paso · USScripps Research Institute · US

Funding

TOXICOLOGY PROJECTG12RR008124 · NCRR · UNIVERSITY OF TEXAS EL PASO · PI AGUILERA, RENATO J · 1992 to 2011
$20.8M
STRUCTURAL STUDIES OF FAAHP01DA017259 · NIDA · SCRIPPS RESEARCH INSTITUTE, THE · PI STEVENS, RAYMOND C · 2004 to 2013
$10.6M
MINORITY RESEARCH TRAINING IN NEUROSCIENCET32MH018882 · NIMH · AMERICAN PSYCHOLOGICAL ASSOCIATION · PI MARTINEZ, JOSEPH L. · 1987 to 2009
$8.7M
Sex Differences in the Mechanisms that Promote Nicotine Reward and WithdrawalR01DA021274 · NIDA · UNIVERSITY OF TEXAS EL PASO · PI ODELL, LAURA ELENA · 2007 to 2019
$4.4M
Summer Mentoring And Research Training: Methods In Neuroscience of Drug-abuse (SMART-MIND)R25DA033613 · NIDA · UNIVERSITY OF TEXAS EL PASO · PI Karina C Canaba, LAURA ELENA ODELL · 2012 to 2026
$1.5M
Effect of nicotine self-administration on endocannabinoids & related lipidsF32DA029994 · NIDA · SCRIPPS RESEARCH INSTITUTE, THE · PI BUCZYNSKI, MATTHEW WALLACE · 2011 to 2013
$161k
Mechanisms of developmental sensitivity to nicotine withdrawalF31DA021133 · NIDA · UNIVERSITY OF TEXAS EL PASO · PI NATIVIDAD, LUIS ALBERTO · 2008 to 2010
$74k
NCRR NIH HHS 5G12RR008124NCRR NIH HHS G12 RR008124NIDA NIH HHS F31 DA021133NIDA NIH HHS F31-DA021133NIDA NIH HHS F32 DA029994NIDA NIH HHS P01 DA017259NIDA NIH HHS P01-DA017259NIDA NIH HHS R01 DA021274NIDA NIH HHS R01-DA021274NIDA NIH HHS R25 DA033613NIMH NIH HHS T32 MH018882NIMH NIH HHS T32-MH018882
6 · The paper itself

Abstract

Adolescent smokers report enhanced positive responses to tobacco and fewer negative effects of withdrawal from this drug than adults, and this is believed to propel higher tobacco use during adolescence. Differential dopaminergic responses to nicotine are thought to underlie these age-related effects, as adolescent rats experience lower withdrawal-related deficits in nucleus accumbens (NAcc) dopamine versus adults. This study examined whether age differences in NAcc dopamine during withdrawal are mediated by excitatory or inhibitory transmission in the ventral tegmental area (VTA) dopamine cell body region. In vivo microdialysis was used to monitor extracellular levels of glutamate and gamma-aminobutyric acid (GABA) in the VTA of adolescent and adult rats experiencing nicotine withdrawal. In adults, nicotine withdrawal produced decreases in VTA glutamate levels (44% decrease) and increases in VTA GABA levels (38% increase). In contrast, adolescents did not exhibit changes in either of these measures. Naïve controls of both ages did not display changes in NAcc dopamine, VTA glutamate, or VTA GABA following mecamylamine. These results indicate that adolescents display resistance to withdrawal-related neurochemical processes that inhibit mesolimbic dopamine function in adults experiencing nicotine withdrawal. Our findings provide a potential mechanism involving VTA amino acid neurotransmission that modulates age differences during withdrawal.

Indexed as

Adaptation, PhysiologicalAge FactorsAnalysis of VarianceAnimalsChromatography, High Pressure LiquidDialysisDopamineElectrochemistrygamma-Aminobutyric AcidGlutamic AcidLimbic SystemMaleMecamylamineNicotineNicotinic AgonistsNicotinic AntagonistsDopaminegamma-Aminobutyric AcidGlutamic AcidMecamylamineNicotineNicotinic AgonistsNicotinic Antagonists

Identifiers

PMID22905672
PMCPMC3472122
OpenAlexW2167223178

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.